|
UNITED
STATES |
OMB APPROVAL |
|
OMB Number: 3235-0582 |
|
|
Expires: April 30, 2009 |
|
|
Estimated average burden hours per response......14.4 |
FORM N-PX
ANNUAL
REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-06565
H&Q Life Sciences Investors
(Exact name of registrant as specified in charter)
30 Rowes Wharf, Boston, MA |
|
02110 |
(Address of principal executive offices) |
|
(Zip code) |
Carolyn Haley
H&Q Life Sciences Investors
30 Rowes Wharf, Boston MA 02110
(Name and address of agent for service)
Registrants telephone number, including area code: 617 772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/06-6/30/07
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrants proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (OMB) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
HQL N-PX for the period July 1, 2006 to June 30, 2007
CUSIP |
|
Symbol |
Company Name |
|
|
||
004225108 |
|
ACAD |
Acadia Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/15/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Gordon Binder |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Leslie L. Iversen |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the audit committee of our board of directors of Pricewaterhousecoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
Agensys, Inc. |
|
|
|
Action by Written Consent: |
6/29/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of amended and restated articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Disclosure of interested parties in stock financing |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Waiver of notice and right of first refusal |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
General authorization |
|
For |
|
Yes |
|
For |
|
Management |
|
009728106 |
|
AKRX |
Akorn, Inc. |
|
|
||
Meeting Date: |
5/24/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director John N. Kapoor, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Arthur S. Przybyl |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jerry N. Ellis |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ronald M. Johnson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jerry I. Treppel |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Subhash Kapre, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Randall J. Wall |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the selection of BDO Seidman, LLP to serve as Akorns independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
016255101 |
|
ALGN |
Align Technology, Inc. |
|
|
||
Meeting Date: |
5/23/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director H. Kent Bowen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David E. Collins |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph Lacob |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director C. Raymond Larking, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George J. Morrow |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas M. Prescott |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Greg J. Santora |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Warren S. Thaler |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the appointment of Pricewatershousecoopers LLP as Algin Technology, Inc.s independent registered public accountants for the fiscal year dending December 31, 2007. |
|
For |
|
Yes |
|
For |
|
Management |
|
02043Q107 |
|
ALNY |
Alnylam Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/1/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Victor J. Dzau,MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kevin P. Starr |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment by the board of directors of Pricewaterhousecoopers LLP, an independent registered public accounting firm, as the companys independent auditors for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
031162100 |
|
AMGN |
Amgen, Inc. |
|
|
||
Meeting Date: |
5/9/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/12/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Frank J. Biondi, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jerry D. Choate |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Frank C. Herringer |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gilbert S. Omenn |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratify the selection of Ernst & Young LLP as the companys independent registered public accountants for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the amendments to the companys restated certificate of incorporation eliminating the classification of the board of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To approve the amendments to the companys amended and restated bylaws eliminating the classification of the board of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Shareholder proposal #1 on animal welfare policy |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
6 |
|
Shareholder proposal #2 on sustainability report |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/23/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Steven R. Altman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Teresa Beck |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Daniel M. Bradbury |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph C. Cook, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Karin Eastham |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James R. Gavin III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ginger L. Graham |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Howard E. Greene, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jay S. Skyler |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph P. Sullivan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James N. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an increase of 250,000 shares in the aggregate number of shares of the companys common stock authorized for issuance under the companys amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve an increase of 1,000,000 shares in the aggregate number of shares of the companys common stock authorized for issuance under the companys 2001 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To ratify the selection of Ernst & Young LLP as independent auditors of the company for its fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
040047102 |
|
ARNA |
Arena Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/11/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Jack Lief |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dominic P. Behan, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Donald D. Belcher |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Scott H. Bice |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Harry F. Hixson, Jr., Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director J.C. La Force, Jr., Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Tina S. Nova, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Christine A. White, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of appointment of Ernst & Young LLP as independent auditors |
|
For |
|
Yes |
|
For |
|
Management |
|
04538T109 |
|
ASPV |
Aspreva Pharmaceuticals Corporation |
|
|||
Meeting Date: |
5/31/2007 |
|
Meeting Type: |
Annual and Special |
|||
Record Date: |
4/19/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Richard M. Glickman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Noel F. Hall |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kirk K. Calhoun |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ronald M. Hunter |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William L. Hunter |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Julia G. Levy |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director R. Hector Mackay-Dunn |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George M. Milne |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Arnold L. Oronsky |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To appoint Ernst & Young LLP as our auditor and independent registered public accounting firm for the ensuing year |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To amend the Aspreva 2002 incentive stock option plan to increase from 4,031,000 to 5,281,000 common shares in respect of which awards may be granted thereunder |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To amend the Aspreva 2002 incentive stock option plan to (I) comply with recent policies of the Toronto stock exchange: (II) premit the award to tandem stock appreciation rights, restricted stock units and deferred stock units: and (III) certain other changes |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
To transact such other business as may properly come before the meeting, or any adjournments or postponements thereof |
|
For |
|
Yes |
|
For |
|
Management |
|
05346P106 |
|
AVRX |
Avalon Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/7/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/20/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director K.C. Carter, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director D.S. Kabakoff, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael R. Kurman, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bradley G. Lorimier |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ivor Royston, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William A. Scott, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director A.G. Walton, Ph.D., D.Sc. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William H. Washecka |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the amendment of the companys 2005 omnibus long-term incentive plan (the incentive plan) to increase the number of shares available for issuance under the incentive plan from 1,581,582 shares to 2,381,582 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
05365U101 |
|
AVTQY |
Aveta Inc. 144A |
|
|
||
Meeting Date: |
10/20/2006 |
|
Meeting Type: |
Annual |
|||
Record Date: |
9/19/2006 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Christina Foglio |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George Zoffinger |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the Aveta Inc. amended and restated 2005 stock incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
06850R108 |
|
BTRX |
Barrier Therapeutics, Inc. |
|
|
||
Meeting Date: |
6/6/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director S. Akkaraju, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert E. Campbell |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Geert Cauwenbergh, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
09059N100 |
|
BIVN |
Bioenvision, Inc. |
|
|
||
Meeting Date: |
12/15/2006 |
|
Meeting Type: |
Annual |
|||
Record Date: |
10/18/2006 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Christopher B. Wood, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael Kauffman, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas Scott Nelson, CA |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Steven A. Elms |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Andrew Schiff, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph P. Cooper |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Amendment to 2003 stock incentive plan to approve and adopt an amendment to our 2003 stock incentive plan to increase the number of shares that may be granted under the plan from 4,500,000 to 6,750,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
The proposal to ratify the appointment of J.H. Cohn LLP as the companys independent auditors for the fiscal year ending June 30, 2007. |
|
For |
|
Yes |
|
For |
|
Management |
|
09062X103 |
|
BIIB |
Biogen Idec Inc. |
|
|
||
Meeting Date: |
5/31/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director James C. Mullen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bruce R. Ross |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Marijn E. Dekkers |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Pricewaterhousecoopers LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
09061G101 |
|
BMRN |
Bimarin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/7/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Jean-Jacques Bienaime |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael Grey |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Elaine J. Heron |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph Klein, III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Pierre Lapalme |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director V. Bryan Lawlis |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Alan J. Lewis |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard A. Meier |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the selection by the board of directors of KPMG LLP as the companys independent registered public accounting firm for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
14075T107 |
|
CPD |
Caraco Pharmaceutical Laboratories, |
|
||
Meeting Date: |
9/11/2006 |
Meeting Type: |
Annual |
|||
Record Date: |
7/25/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Dilip S. Shanghvi |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jitendra N. Doshi |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dr. John D. Crissman |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
CardioNet, Inc. |
|
|
|
Action by Written Consent: |
8/21/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approve financing; articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Waiver of rights of first offer |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Additional filings |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Ratification; general authorizing resolution |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
CardioNet, Inc. |
|
|
Action by Written Consent: |
1/11/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Increase in share reserve under equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendment and restatement of articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
General authorizing resolution; ratification of past acts |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
CardioNet, Inc. |
|
|
Action by Written Consent: |
3/30/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of financing |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendment and restatement of articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of additional filings |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
General authorizing resolution |
|
For |
|
Yes |
|
For |
|
Management |
|
151020104 |
|
CELG |
Celgene Corporation |
|
|
|
Meeting Date: |
6/12/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/26/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Sol J. Barer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert J. Hugin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael D. Casey |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Rodman L. Drake |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director A. Hull Hayes, Jr., MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gilla Kaplan, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James J. Loughlin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard C.E. Morgan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Walter L. Robb, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
156708109 |
|
CEPH |
Cephalon, Inc. |
|
|
|
Meeting Date: |
5/17/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/22/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Frank Bladino, Jr., Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William P. Egan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Martyn D. Greenacre |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Vaughn M. Kailian |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kevin E. Moley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles A. Sanders, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gail R. Wilensky, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dennis L. Winger |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendment to the certificate of incorporation increasing the number of shares of common stock authorized for issuance |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of amendment to the 2004 equity compensation plan increasing the number of shares of common stock authorized for issuance |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Ratification of appointment of Pricewaterhousecoopers LLP as independent registered public accountants for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
N/A |
|
N/A |
Ceres, Inc. |
|
|
|
Meeting Date: |
5/31/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/26/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Walter De Logi |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Pascal Brandys |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Frank Bulens |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Raymond Debbane |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert Goldberg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard Hamilton |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas Kiley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Edmund Olivier |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Floris Vansina |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the appointment of KPMG LLP as independent public accountants |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Ceres, Inc. |
|
|
Action by Written Consent: |
5/8/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Election of Directors |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Concentric Medical, Inc. |
|
|
Action by Written Consent: |
8/30/2006 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Appointment of Secretary and Assistant Secretary |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Omnibus resolutions |
|
For |
|
Yes |
|
For |
|
Management |
|
208264101 |
|
CONR |
Conor Medsystems, Inc. |
|
|
||
Meeting Date: |
1/31/2007 |
|
Meeting Type: |
Special |
|||
Record Date: |
12/15/2006 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To adopt the agreement and plan of merger, dated as of November 16, 2006, by and among Conor Medsystems, Inc., Johnson & Johnson and Cypress Acquisition Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, pursuant to which Merger Sub will be merged with and into Conor Medsystems all as more fully described in the proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the postponement or adjournment of the special meeting, if necessary, to solicit additional proxies in the event that there are insufficient votes at the time of the special meeting to adopt the merger agreement. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Corus Pharma, Inc. |
|
|
Action by Written Consent: |
8/30/2006 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of benefits to employee |
|
For |
|
Yes |
|
For |
|
Management |
|
222083107 |
|
CGRB |
Cougar Biotechnology, Inc. |
|
|
|
Meeting Date: |
6/11/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/23/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Arie S. Belldegrun, MD, FACS |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Alan H. Auerbach |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Lindsay A. Rosenwald, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Harold J. Meyers |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael S. Richman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Russell H. Ellison, MD, MSC |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the appointment of JH Cohn LLP as the companys independent registered public accounting firm for 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Proposal to ratify an amendment to the companys 2003 stock option plan |
|
For |
|
Yes |
|
For |
|
Management |
|
22674T105 |
|
CRTX |
Critical Therapeutics, Inc. |
|
|
|
Meeting Date: |
5/2/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/5/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Jean George |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Frank E. Thomas |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the audit committee of Deloitte & Touche LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
229678107 |
|
CBST |
Cubist Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/7/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Michael W. Bonney |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Walter R. Maupay, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Sylvie Gregoire |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
A proposal to amend our restated certificate of incorporation to increase the number of authorized shares of common stock from 100,000 shares to 150,000,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
A proposal to amend our amended and restated 1997 employee stock purchase plan to extend the plan for an additional ten years and increase the number of shares issuable under the plan by 250,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
A proposal to amend our amended and restated 2002 directors equity incentive plan to allow for the issuance of stock awards and to increase the number of shares issuable under the plan by 300,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
A proposal to ratify the selection of Pricewaterhousecoopers LLP as our independent auditor for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
259858108 |
|
DOVP |
DOV Pharmaceutical, Inc. |
|
|
||
Meeting Date: |
5/11/2007 |
|
Meeting Type: |
Special |
|||
Record Date: |
4/2/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approve an amendment to DOV Pharmaceutical, Inc.s fourth amended and restated certificate of incorporation to increase the number of authorized shares of common stock by 200,000,000, from 60,000,000 to 260,000,000, together with a corresponding increase in the number of authorized shares of capital stock from 66,905,000 to 266,905,000 |
|
For |
|
Yes |
|
For |
|
Management |
|
29076V109 |
|
EMAG |
Emageon, Inc. |
|
|
|
Meeting Date: |
5/24/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/25/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Mylle H. Mangum |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Hugh H. Williamson, III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
|
26881Q101 |
|
EPIX |
Epix Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
8/15/2006 |
Meeting Type: |
Annual & Special |
|||
Record Date: |
6/28/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approve the issuance of shares of Epix common stock in the merger as contemplated by the agreement and plan of merger, dated as of April 3, 2006, by and among Epix Pharmaceuticals, Inc., Epix Delaware, Inc., and Predix Pharmaceuticals Holdings, Inc., all as more full described in the proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to approve an amendment to Epixs amended and restated certificate of incorporation to increasee the number of authorized shares common stock from 40,000,000 shares to 100,000,000 shares, representing an additional 60,000,000 shares, as more fully described in the proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Authorize the Epix board of directors to amend Epixs restated certificate of incorporation to effect a reverse stock split of Epixs issued and outstanding shares of common stock, at such ratio between 1:1.25 to 1:4 to be determined by the Epix board of directors, all as more fully described in proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Elect Director Michael Gilman, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Elect Director Mark Leuchtenberger |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Elect Robert J. Perez |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Proposal to ratify the selection by the audit committee of the Epix board of directors of Ernst & Young LLP as Epixs independent registered public accounting firm for the fiscal year ending December 31, 2006 |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
Proposal to approve the adjournment of the annual meeting, if necessary, to solicit additional proxies, in the event that there are not sufficient votes at the time of the annual meeting to approve proposal No.s 1, 2, and 3 |
|
For |
|
Yes |
|
For |
|
Management |
|
30161Q104 |
|
EXEL |
Exelixis, Inc. |
|
|
|
Meeting Date: |
5/1/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/5/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Alan M. Garber |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Vincent T. Marchesi |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Carl B. Feldbaum |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP as Exelixis independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
368710406 |
|
DNA |
Genetech, Inc. |
|
|
|
Meeting Date: |
4/20/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
2/20/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Herbert W. Boyer |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William M. Burns |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Erich Hunziker |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jonathan K.C. Knowles |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Arthur D. Levinson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Debra L. Reed |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles A. Sanders |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP as independent registrered public accounting firm of Genentech for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
372917104 |
|
GENZ |
Genzyme Corporation |
|
|
|
Meeting Date: |
5/24/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Douglas A. Berthiaume |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gail K. Boureaux |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock covered by the plan by 3,500,000 shares and to merge our 1997 equity incentive plan into the 2004 plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
A proposal to approve the 2007 director equity plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
A proposal to amend the 1999 employee stock purchase plan to increase the number of shares of common stock covered by the plan by 1,500,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
A proposal to amend our bylaws to provide for majority voting for the election of directors in uncontested elections |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
A proposal to ratify the selection of independent auditors for 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
7 |
|
A shareholder proposal that executive severance agreements be approved by shareholders |
|
Against |
|
Yes |
|
Against |
|
Management |
|
375558103 |
|
GILD |
Gilead Sciences, Inc. |
|
|
||
Meeting Date: |
5/9/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/22/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Paul Berg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John F. Cogan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Etienne F. Davignon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James M. Denny |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Carla A. Hills |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John W. Madigan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John C. Martin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gordon E. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Nicholas G. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gayle E. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP by the Audit Committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the proposed amendment to Gileads 2004 equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To approve the proposed amendment to Gileads employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
422211102 |
|
HLEX |
Healthextras, Inc. |
|
|
||
Meeting Date: |
6/5/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Thomas L. Blair |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director William E. Brock |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Edward S. Civera |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of the Healthextras, Inc. management non-equity incentive compensation plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
The ratification of the appointment of Pricewatershousecoopers LLP as independent registered public accountants of Healthextras, Inc. for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
45166R204 |
|
IDIX |
Idenix Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/31/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/5/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director J-P Sommadossi, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles W. Cramb |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas Ebeling |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director W.T. Hockmeyer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas Hodgson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Norman C. Payson, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert E. Pelzer |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director D. Pollard-Knight, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Pamela Thomas-Graham |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an amendment to the companys restated certificate of incorporation, as amended, increasing the number of authorized shares of common stock from 75,000,000 to 125,000,000 shares |
|
For |
|
Yes |
|
For |
|
|
|
3 |
|
To approve an amendment to the companys 2005 stock incentive plan increasing the number of shares of common stock authorized for issuance thereunder from 3,000,000 shares to 6,000,000 shares |
|
For |
|
Yes |
|
For |
|
|
|
4 |
|
To ratify the selection of Pricewaterhousecoopers LLP as the companys independent registered public accounting firm for the current year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
|
|
45168D104 |
|
IDXX |
Idexx Laboratories, Inc. |
|
|
||
Meeting Date: |
5/9/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Jonathan W. Ayers |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert J. Murray |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Amendment to Idexx Laboratories, Inc. 2003 stock incentive plan. To approve and adopt a proposed amendment to our 2003 stock incentive plan to increase the number of shares authorized under the plan from 1,850,000 to 3,150,000 shares. |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Ratification of appointment of independent registered public accounting firm. To ratify the selection by the audit committee of the board of directors of Pricewaterhousecoopers LLP as the companys independent registered public accounting firm for the current fiscal year. |
|
For |
|
Yes |
|
For |
|
Management |
|
457733103 |
|
ISPH |
Inspire Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/8/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Christy L. Shaffer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard S. Kent, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the selection of Pricewaterhousecoopers LLP as out independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of a proposal to ratify and approve our amended and restated 2005 equity compensation plan |
|
For |
|
Yes |
|
Against |
|
Management |
|
IMA |
|
46126P106 |
Inverness Medical Innovations, Inc. |
|
|
|
Meeting Date: |
5/17/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/23/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Robert P. Khederian |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David Scott, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Peter Townsend |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of grant of options under our 2001 stock option and incentive plan to certain executive officers. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Labcyte, Inc. |
|
|
Action by Written Consent: |
1/17/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Consent to incurring indebtedness |
|
For |
|
Yes |
|
For |
|
Management |
|
50540R409 |
|
LH |
Laboratory Corp. of America Holdings |
|
||
Meeting Date: |
5/16/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Thomas P. MacMahon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kerrii B. Anderson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jean-Luc Belingard |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David P. King |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Wendy E. Lane |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director R.E. Mittelstaedt, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director A.H. Rubenstein, MBBCH |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bradford T. Smith |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director M. Keith Weikel, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director R. Sanders Williams, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the appointment of Pricewatershousecoopers LLP as Laboratory Coporation of America Holdings independent registered public accounting firm for 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
528872104 |
|
LEXG |
Lexicon Genetics, Inc. |
|
|
||
Meeting Date: |
4/25/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/6/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director R.J. Lefkowitz, M.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Alan S. Nies, M.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Clayton S. Rose |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification and approval of an amendment to the companys restated certificate of incorporation changing the name of the company to Lexicon Pharmaceuticals, Inc. |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Ratification and approval of the appointment of Ernst & Young LLP as the companys independent auditors for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Magellan Biosciences, Inc.. |
|
|
Action by Written Consent: |
10/26/2006 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Election of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
General authorization |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Magellan Biosciences, Inc. |
|
|
Action by Written Consent: |
1/31/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Sale of assets |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of the companys entry into retention agreements |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
General authorization |
|
|
|
|
|
|
|
|
|
|
Magellan Biosciences, Inc. |
|
|
Action by Written Consent: |
4/30/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Purchase of intellectual property assets |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Consent to consulting agreements |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of stock options grant |
|
For |
|
Yes |
|
For |
|
Management |
|
56400P201 |
|
MNKD |
Mannkind Corporation |
|
|
||
Meeting Date: |
5/24/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/2/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Alfred E. Mann |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Hakan S. Edstrom |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Barry E. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ronald J. Consiglio |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael A. Friedman, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Heather May Murren |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kent Kresa |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David H. Maccallum |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Henry L. Nordhoff |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Increase the number of authorized shares of common stock from 90 million to 150 million |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Ratification of Deloitte & Touche LLP as independent auditors |
|
For |
|
Yes |
|
For |
|
Management |
|
576818108 |
|
MZT |
Matritech, Inc. |
|
|
||
Meeting Date: |
6/8/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Stephen D. Chubb |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David L. Corbet |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Walter O. Fredericks |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Judith Kurland |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bruce Lehman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David B. Musket |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jonathan M. Niloff |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert J. Rosenthal |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard A. Sandberg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director T. Stephen Thompson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director C. William Zadel |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve issuances by the company of shares of common stock to satisfy the companys obligations under certain convertible, secured promissory notes at a price below $0.63 per share |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve issuances by the company of shares of common stock at a price below $0.63 per share upon exercise of certain warrants |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To ratify the selection of Pricewaterhousecoopers LLP as the companys independent registered public accouting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Matritech, Inc. |
|
|
Action by Written Consent: |
1/13/2007 |
|
|
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
1 |
|
Amendment to notes |
|
For |
|
Yes |
|
For |
|
Management |
|
|
Matritech, Inc. |
|
|
Action by Written Consent: |
2/22/2007 |
|
|
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of a change to the annual meeting date |
|
For |
|
Yes |
|
For |
|
Management |
|
583916101 |
|
MEDX |
Medarex, Inc. |
|
|
||
Meeting Date: |
5/17/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/5/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Abhijeet J. Lele |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Irwin Lerner |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Julius A. Vida |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director R.C. Dinerstein |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
The ratification of the selection by the board of Ernst & Young LLP as Medarexs independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
58405K104 |
|
MDHC |
Medco Health Solutions, Inc. |
|
|
|
Meeting Date: |
5/24/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/29/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Howard W. Barker, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David B. Snow, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To amend the companys second amended and restated certificate of incorporation to provide for the phase-in of the annual election of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve the 2003 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To ratify the appointment of Pricewaterhousecoopers LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
584690309 |
|
MRX |
Medicis Pharmaceutical Corporation |
|
||
Meeting Date: |
5/22/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/30/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Jonah Shacknai |
|
For |
|
Yes |
|
Yes |
|
Management |
|
1 |
|
Elect Director Michael A. Pietrangelo |
|
For |
|
Yes |
|
Yes |
|
Management |
|
1 |
|
Elect Director Lottie H. Shackelford |
|
For |
|
Yes |
|
Yes |
|
Management |
|
2 |
|
Approval of amendment to No. 3 to the Medicis 2006 incentive award plan |
|
For |
|
Yes |
|
Abstain |
|
Management |
|
3 |
|
Ratification of the selection of Ernst & Young LLP as independent auditors of Medicis for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
Yes |
|
Management |
|
585081102 |
|
MDWV |
Medwave, Inc. |
|
|
|
Meeting Date: |
3/19/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
2/14/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director William D. Corneliuson |
|
For |
|
Yes |
|
For |
|
Management |
|
60877T100 |
|
MNTA |
Momenta Pharmaceuticals, Inc. |
|
|
|
Meeting Date: |
6/13/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/19/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Peter Barrett |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Ram Sasisekharan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bennett M. Shapiro |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the audit committee of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
62855J104 |
|
MYGN |
Myriad Genetics, Inc. |
|
|
||
Meeting Date: |
11/16/2006 |
|
Meeting Type: |
Annual |
|||
Record Date: |
9/29/2006 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Robert S. Attiyeh |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John T. Henderson, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to amend the 2003 employee, director and consultant stock option plan to increase the number of shares of common stock available for issuance thereunder by 1,500,000 shares |
|
For |
|
Yes |
|
Against |
|
Management |
|
3 |
|
Proposal to amend the employee stock purchase plan to increase the number of shares of common stock available for issuance thereunder by 400,000 shares |
|
For |
|
Yes |
|
Against |
|
Management |
|
4 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending June 30, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
636918302 |
|
NMHC |
National Medical Health Card Systems, Inc. |
|
||
Meeting Date: |
4/17/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director James Smith |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Paul J. Konigsberg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Steven B. Klinsky |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director G. Harry Durity |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert R. Grusky |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Daniel B. Hebert |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gerald Angowitz |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael B. Ajouz |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael T. Flaherman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Thomas W. Erickson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of engagement of Ernst & Young LLP to serve as the independent registered public accounting firm of National Medical Health Card Systems, Inc. for the fiscal year ending June 30, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
639050103 |
|
BABY |
Natus Medical Incorporated |
|
||
Meeting Date: |
6/14/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/27/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Robert A. Gunst |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James B. Hawkins |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Proposal to ratify the appointment of Deloitte & Touche LLP as Natus Medical Incorporateds independent registered public accounting firm for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
654798503 |
|
NTMD |
Nitromed, Inc. |
|
|||
Meeting Date: |
5/25/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/4/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director A.N. Karabelas, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kenneth M. Bate |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert S. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director F.L. Douglas, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Zola Horovitz, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Mark Leschly |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John W. Littlechild |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph Loscalzo, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Davey S. Scoon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Christopher J. Sobecki |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the Audit Committee of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
OmniSonics Medical Technologies, Inc. |
|
||
Action by Written Consent: |
7/10/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Electio of Directors |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
General authorization |
|
For |
|
Yes |
|
For |
|
Management |
|
68750U102 |
|
VITA |
Orthovita, Inc. |
|
||
Meeting Date: |
7/24/2006 |
Meeting Type: |
Annual |
|||
Record Date: |
4/28/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Morris Cheston, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director David Fitzgerald |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Joseph L. Harris |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Antony Koblish |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert M. Levande |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Mary Paetzold |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Russell B. Whitman |
|
For |
|
Yes |
|
For |
|
Management |
|
69811Q106 |
|
PANC |
Panacos Pharmaceuticals, Inc. |
|
||
Meeting Date: |
6/12/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/23/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Dr. Dunton |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Mr. Limber |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Mr. Savage |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the amendment to the companys certificate of incorporation to reduce the number of authorized shares of common stock |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To ratify the appointment of KPMG LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
69329Y104 |
|
PDLI |
PDL Biopharma, Inc. |
|
||
Meeting Date: |
6/20/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/23/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Laurence J. Korn, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Samuel Broder, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an amendment to the companys 2005 equity incentive plan to increase the number of shares of common stock authorized for issuance under the plan by 2,900,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve an amendment to the companys 1993 employee stock purchase plan to increase the number of shares of common stock authorized for issuance under the plan by 500,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
714046109 |
|
PKI |
Perkinelmer, Inc. |
|
|||
Meeting Date: |
4/24/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
2/26/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Robert F. Friel |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Nicholas A. Lopardo |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Alexis P. Michas |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James C. Mullen |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dr. Vicki L. Sato |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gabriel Schmergel |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kenton J. Sicchitano |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gregory L. Summe |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director G. Robert Tod |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the appointment of Deloitte & Touche LLP as Perkinelmers independent auditors for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve amendments to the companys articles of organization and by-laws to require a majority vote for uncontested election of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Shareholder proposal to request that the companys board of directors establish a pay-for-superior-performance standard in the companys executive compensation plan for senior executives. The board of directors recommend a vote against proposal 4. |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
7171EP101 |
|
PCOP |
Pharmaceopeia Drug Discovery, Inc. |
|
|||
Meeting Date: |
5/4/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/14/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Steven J. Burakoff |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bruce A. Peacock |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Martin H. Soeters |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dennis H. Langer |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of the appointment of Ernst & Young LLP as the companys independent external auditors for the period commencing January 1, 2007 and ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of the amendment of the companys amended and restated certificate of incorporation to change the name of the company to Pharmacopeia, Inc. |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Approval of the amended and restated 2004 stock incentive plan. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
PHT Corporation |
|
|
Action by Written Consent: |
1/31/2007 |
|
|
||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of the Corporation entering into an agreement |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of the Coporation entering into an equipement arrangement |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
PHT Corporation |
|
|
Action by Written Consent: |
3/30/2007 |
|
|
||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Resignation and election of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
General authorization |
|
For |
|
Yes |
|
For |
|
Management |
|
743187106 |
|
PGNX |
Progenics Pharmaceuticals, Inc. |
|
||
Meeting Date: |
6/11/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Kurt W. Briner |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Paul F. Jacobson |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles A. Baker |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Mark F. Dalton |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Stephen P. Goff, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director PJ Maddon, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director DA Scheinberg, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Nicole S. Williams |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amendments to the 1998 employee stock purchase plan and the 1998 non-qualified employee stock purchase plan to increase the number of shares of common stock reserved for issuance thereunder to 1,600,000 and 500,000 respectively, and to make certain other changes to the terms of the plans |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Approval of an amendment to the 2005 stock incentive plan to increase the number of shares of common stock reserved for issuance thereunder to 3,950,000 and to make certain other changes to the terms of the plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Ratification of the selection of Pricewatershousecoopers LLP to serve as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Authority to vote in their discretion on such other business as may properly come before the meeting |
|
For |
|
Yes |
|
For |
|
Management |
|
766559603 |
|
RIGL |
Rigel Pharmaceuticals, Inc. |
|
||
Meeting Date: |
5/31/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/22/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Jean Deleage, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director P.S. Ringrose, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Bradford S. Goodwin |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve an amendment to the companys 2000 equity incentive plan (the 2000 plan) to increase the number of shares authorized for issuance under the 2000 plan to an aggregate total of 8,410,403 |
|
For |
|
Yes |
|
Against |
|
Management |
|
3 |
|
To approve an amendment to the companys 2000 non-employee directors stock plan (the directors plan) to increase the number of shares authorized for issuance under the directors plan to an aggregate total of 435,000 |
|
For |
|
Yes |
|
Against |
|
Management |
|
4 |
|
To approve an amendment to the companys 2000 employee stock purchase plan (the purchase plan) to (1) increase the number of shares authorized for purchase under the purchase plan to an aggregate total of 1,964,062 and (II) terminate the provision providing for an annual increase to the purchase plan pursuant to section 3(A) of the purchase plan effective January 1, 2008 |
|
For |
|
Yes |
|
Against |
|
Management |
|
5 |
|
To ratify the selection by the Audit Committee of the board of directors of Ernst & Young LLP as independent registered public accounting firm of the company for its fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
81724Q107 |
|
SNMX |
Senomyx, Inc. |
|
||
Meeting Date: |
5/31/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/11/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Stephen A. Block, Esq. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael E. Herman |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Mark Leschly |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Dennis F. OBrien |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jay M. Short, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kent Snyder |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Christopher J. Twomey |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the audit committee of our board of directors of Ernst & Young LLP as our independent auditors for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
82481R106 |
|
SHPGY |
Shire plc |
|
||
Meeting Date: |
4/16/2007 |
Meeting Type: |
Special |
|||
Record Date: |
3/26/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To approve the acquisition by the Company of New River Pharmaceuticals, Inc. and approve the increase in the borrowing limits of the Company. |
|
For |
|
Yes |
|
For |
|
Management |
|
82481R106 |
|
SHPGY |
Shire plc |
|
||
Meeting Date: |
6/20/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
- |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To receive the directors report and accounts for the year ended December 31 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To re-elect Director Dr. James Henry Cavanaugh |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To re-elect Director Dr. Barry John Price |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To elect Director Ms. Kathleen Anne Nealon |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
To elect Director Dr. Jeffrey Marc Leiden |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
To re-elect Director Mr. Matthew William Emmens |
|
For |
|
Yes |
|
For |
|
Management |
|
7 |
|
To re-elect Director Mr. David John Kappler |
|
For |
|
Yes |
|
For |
|
Management |
|
8 |
|
To re-elect Director Mr. Patrick Langlois |
|
For |
|
Yes |
|
For |
|
Management |
|
9 |
|
To re-appoint Deloitte & Touche LLP as auditors of the company |
|
For |
|
Yes |
|
For |
|
Management |
|
10 |
|
To authorize the Audit Committee to determine the renumberation of the auditors |
|
For |
|
Yes |
|
For |
|
Management |
|
11 |
|
To approve the directors renumeration report for the year ended December 31, 2006 |
|
For |
|
Yes |
|
For |
|
Management |
|
12 |
|
To authorize the allotment of shares |
|
For |
|
Yes |
|
For |
|
Management |
|
13 |
|
To authorize the disapplication of pre-emption rights |
|
For |
|
Yes |
|
For |
|
Management |
|
14 |
|
To authorize market purchases |
|
For |
|
Yes |
|
For |
|
Management |
|
15 |
|
To authorize donations to EU political organizations and the incurring of EU political expenditure |
|
For |
|
Yes |
|
For |
|
Management |
|
16 |
|
To approve the rules of the 2007 Shire plc employee stock purchase plan and to authorize the directors to make modifications and establish further plans |
|
For |
|
Yes |
|
For |
|
Management |
|
871546206 |
|
SMA |
Symmetry Medical, Inc. |
|
|||
Meeting Date: |
5/3/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/19/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director James S. Burns |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of appointment of Ernst & Young LLP as independent auditors |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
TargeGen, Inc. |
|
|
Action by Written Consent: |
5/8/2007 |
|
|
||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of issuance of stock |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of amended and restated articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Amendment to stock option plan |
|
For |
|
Yes |
|
For |
|
Management |
|
88078L105 |
|
TRCA |
Tercica, Inc. |
|
|||
Meeting Date: |
10/12/2006 |
|
Meeting Type: |
Special |
|||
Record Date: |
8/28/2006 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To approve the issuance of securities to Ipsen, S.A. or its designated affiliate in connection with the transactions contemplated by the stock purchase and master transaction agreement, dated July 18, 2006, between Tercica and Ipsen S.A., as described in the accompanying proxy statement. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the amendments to Tercicas amended and restated certificate of incorporation and amended and restated bylaws, as described in the accompanying proxy statement. |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve additional amendments to Tercicas amended and restated certificate of incorporation, as described in the accompany proxy statement. |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
To approve the adoption by Tercica of a rights agreement implementing a stockholder rights plan, as described in the accompanying proxy statement. |
|
For |
|
Yes |
|
For |
|
Management |
|
881624209 |
|
TEVA |
Teva Pharmaceutical Industries ADR |
|
||
Meeting Date: |
10/5/2006 |
Meeting Type: |
Special |
|||
Record Date: |
8/29/2006 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
To approve the remuneration of Mr. Eli Hurvitz in his capacity of chairman of the board of Teva, in an amount of the NIS equivalent of $300,000 per annum plus VAT, to be adjusted by the increase of the Israeli consumer price index, together with an office and secretarial and car services. Such remuneration is to be effective as of July 3, 2006. |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve the remuneration of Dr. Phillip Frost in his capacity as vice chairman of the board of Teva and chairman of the boards science and technology committee, in an amount of the NIS equivalent of $275,000 per annum plus VAT, to be adjusted by the increase of the Israeli consumer price index. Such remuneration is to be effective as of July 3, 2006. |
|
For |
|
Yes |
|
For |
|
Management |
|
883556102 |
|
TMO |
Thermo Fisher Scientific Inc. |
|
||
Meeting Date: |
5/15/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/29/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Marijn E. Dekkers |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval and adoption of the Thermo Fisher Scientific Inc. 2007 employees stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Ratification of selection of independent auditors |
|
For |
|
Yes |
|
For |
|
Management |
|
91324P102 |
|
UNH |
Unitedhealth Group Incorporated |
|
|||
Meeting Date: |
5/29/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/9/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director William C. Ballard, Jr |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard T. Burke |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Stephen J. Hemsley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Robert J. Darretta |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Amendment to articles of incorporation requiring a majority vote for election of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Amendment to articles of incorporation and bylaws providing for the annual election of all members of the board of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Amendment to articles of incorporation and bylaws to eliminate supermajority provisions for the removal of directors |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Amendment to articles of incorporation to eliminate supermajority provisions relating to certain business combinations |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
Adoption of restated articles of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
7 |
|
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
8 |
|
Shareholder proposal concerning performance-vesting shares |
|
Against |
|
Yes |
|
For |
|
Shareholder |
|
9 |
|
Shareholder proposal concerning supplemental executive retirement plan |
|
Against |
|
Yes |
|
For |
|
Shareholder |
|
10 |
|
Shareholder proposal concerning an advisory resolution on compensation of named executive officeres |
|
For |
|
Yes |
|
Against |
|
Shareholder |
|
11 |
|
Shareholder proposal relating to shareholder nominees for election to Unitedhealth Groups barod of directors |
|
Against |
|
Yes |
|
For |
|
Shareholder |
|
92846N104 |
|
VTAL |
Vital Images, Inc. |
|
||
Meeting Date: |
5/22/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/23/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Douglas M. Pihl |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jay D. Miller |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James B. Hickey, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Gregory J. Peet |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard W. Perkins |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Michael W. Vannier, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Sven A. Wehrwein |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Approval of the amendment to the companys articles of incorporation increasing the number of authorized shares of common stock |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Ratification of the appointment of Pricewaterhousecoopers LLP as the companys independent registered public accounting firm for the year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
928566108 |
|
VNUS |
VNUS Medical Technologies, Inc. |
|
|||
Meeting Date: |
5/18/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/2/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director W. James Fitzsimmons |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Brian E. Farley |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Ratification of appointment of independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
|
94973V107 |
|
WLP |
WellPoint, Inc. |
|
||
Meeting Date: |
5/16/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
3/15/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Sheila P. Burke |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Victor S. Liss |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jane G. Pisano, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director George A. Schaefer, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Jackie M. Ward |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John E. Zuccotti |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To approve majority voting for the election of directors in non-contested elections |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the company for 2007. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
Xanthus Pharmaceuticals, Inc. |
|
|
Action by Written Consent: |
11/6/2006 |
|
|
||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Issuance of securities |
|
For |
|
No |
|
None |
|
Management |
|
2 |
|
Amendment of certificate of incorporation |
|
For |
|
No |
|
None |
|
Management |
|
3 |
|
Waiver of rights of first refusal |
|
For |
|
No |
|
None |
|
Management |
|
4 |
|
Approval of new purchasers |
|
For |
|
No |
|
None |
|
Management |
|
5 |
|
Adoption of employee perfomance incentive plan |
|
For |
|
No |
|
None |
|
Management |
|
|
|
|
Xanthus Pharmaceuticals, Inc. |
|
|
Action by Written Consent: |
4/30/2007 |
|
|
||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Amendment to certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Issuance of securities |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Waiver of rights of first refusal |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Amendment to stockholders agreement |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Approval of officers of Company with power of attorney |
|
For |
|
Yes |
|
For |
|
Management |
|
6 |
|
Amendment to stock option plan |
|
For |
|
Yes |
|
For |
|
Management |
|
98411C100 |
|
XNPT |
Xenoport, Inc. |
|
||
Meeting Date: |
5/30/2007 |
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2007 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Paul L. Berns |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director John G. Freund, MD |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Kenneth J. Nussbacher |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2007 |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
Xoft, Inc. |
|
|
Action by Written Consent: |
3/30/2007 |
|
|
||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Approval of amended and restated certificate of incorporation |
|
For |
|
No |
|
None |
|
Management |
|
2 |
|
Approval of financing |
|
For |
|
No |
|
None |
|
Management |
|
3 |
|
Approval of financing documents |
|
For |
|
No |
|
None |
|
Management |
|
4 |
|
Approval of changes to stock plan |
|
For |
|
No |
|
None |
|
Management |
|
5 |
|
Appointment of Director |
|
For |
|
No |
|
None |
|
Management |
|
6 |
|
Approval of indemnification of agreements |
|
For |
|
No |
|
None |
|
Management |
|
7 |
|
Approval of issuance of warrants |
|
For |
|
No |
|
None |
|
Management |
|
8 |
|
Approval of omnibus resolution |
|
For |
|
No |
|
None |
|
Management |
|
98974P100 |
|
ZIXI |
Zix Corporation |
|
|||
Meeting Date: |
6/7/2007 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/12/2007 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect Director Robert C. Hausmann |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Charles N. Kahn III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director James S. Marston |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Antonio R. Sanchez III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Paul E. Schlosberg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect Director Richard D. Spurr |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
Adoption of proposed amendments to Zix Corporation 2006 directors stock option plan |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
Adoption of proposed amendments to Zix Corporation 2004 stock option plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
Adoption of proposed amendment to Zix Corporation employee stock option plan |
|
For |
|
Yes |
|
For |
|
Management |
|
5 |
|
Ratification of appointment of Whitley Penn LLP as independent registered public accountants |
|
For |
|
Yes |
|
For |
|
Management |
|
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) |
H&Q Life Sciences Investors |
||||
|
|||||
By (Signature and Title)* |
|
|
|||
|
|
(Daniel Omstead, President) |
|||
|
/s/ Daniel Omstead |
||||
|
|||||
Date |
8/24/07 |
||||
*Print the name and title of each signing officer under his or her signature.
2